Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Figuring out how to structure your days so they're as productive as possible is a challenge, which is why there are so many different techniques for doing it, though they're all best suited to ...

US Secretary of State Marco Rubio has directed the State Department to go back to using Times New Roman typeface as the standard for official papers, a spokesperson told CNN, in a reversal of the ...

Nearly a third of US teenagers say they use AI chatbots daily, a new study finds, shedding light on how young people are embracing a technology that’s raised critical safety concerns around mental ...